| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Histone-lysine N-methyltransferase SMYD3 |
|---|
| Ligand | BDBM377919 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1576443 (CHEMBL3803120) |
|---|
| IC50 | >10000±n/a nM |
|---|
| Citation |  Mitchell, LH; Boriack-Sjodin, PA; Smith, S; Thomenius, M; Rioux, N; Munchhof, M; Mills, JE; Klaus, C; Totman, J; Riera, TV; Raimondi, A; Jacques, SL; West, K; Foley, M; Waters, NJ; Kuntz, KW; Wigle, TJ; Scott, MP; Copeland, RA; Smith, JJ; Chesworth, R Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor. ACS Med Chem Lett7:134-8 (2016) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Histone-lysine N-methyltransferase SMYD3 |
|---|
| Name: | Histone-lysine N-methyltransferase SMYD3 |
|---|
| Synonyms: | SET and MYND domain-containing protein 3 | SMYD3 | SMYD3_HUMAN | ZMYND1 | ZNFN3A1 | Zinc finger MYND domain-containing protein 1 |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 49101.22 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q9H7B4-2 |
|---|
| Residue: | 428 |
|---|
| Sequence: | MEPLKVEKFATAKRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLM
RCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSES
EKLYSFYDLESNINKLTEDKKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVIC
NSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYL
DMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHW
KWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRI
FFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEE
CDANIRAS
|
|
|
|---|
| BDBM377919 |
|---|
| n/a |
|---|
| Name | BDBM377919 |
|---|
| Synonyms: | 2-oxo-N-(piperidin-4-yl)indoline-5-carboxamide | US10266526, Compound 50 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C14H17N3O2 |
|---|
| Mol. Mass. | 259.3037 |
|---|
| SMILES | O=C(NC1CCNCC1)c1ccc2NC(=O)Cc2c1 |
|---|
| Structure | 
|
|---|
Search and Browse
